Accretion Nutraveda Limited (BOM:544694)
India · Delayed Price · Currency is INR 286.00
+9.00 (3.25%)
At close: Aug 21, 2026
Accretion Nutraveda Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 336.03 | 160.02 | 50.05 | 29.03 | 5.85 |
Other Revenue | 0.12 | - | 0.64 | 1 | - |
| 336.15 | 160.02 | 50.69 | 30.03 | 5.85 | |
Revenue Growth | 110.07% | 215.69% | 68.81% | 413.23% | - |
Cost of Revenue | 242.26 | 106.01 | 28.93 | 17.34 | 3.51 |
Gross Profit | 93.89 | 54.01 | 21.76 | 12.69 | 2.34 |
Selling, General & Admin | 12.51 | 6.21 | 4.2 | 2.74 | 1.13 |
Other Operating Expenses | 12.3 | 10.53 | 4.1 | 2.45 | 1.39 |
Operating Expenses | 27.41 | 18.95 | 10.92 | 8.3 | 4.25 |
Operating Income | 66.48 | 35.06 | 10.85 | 4.39 | -1.91 |
Interest Expense | -4.54 | -2.78 | -2.22 | -1.61 | -0.81 |
Interest & Investment Income | 1 | 0.02 | 0.69 | 0.4 | 0.01 |
Currency Exchange Gain (Loss) | -0.01 | 0.01 | - | - | - |
Other Non Operating Income (Expenses) | -0.81 | -0.77 | -0.18 | -0.3 | -0.98 |
Pretax Income | 62.11 | 31.53 | 9.15 | 2.87 | -3.69 |
Income Tax Expense | 11.43 | 6.52 | 0.93 | 0.07 | 0.15 |
Net Income | 50.68 | 25.01 | 8.22 | 2.81 | -3.84 |
Net Income to Common | 50.68 | 25.01 | 8.22 | 2.81 | -3.84 |
Net Income Growth | 102.66% | 204.28% | 192.91% | - | - |
Shares Outstanding (Basic) | 5 | 4 | 4 | 4 | 359 |
Shares Outstanding (Diluted) | 5 | 4 | 4 | 4 | 359 |
Shares Change | 49.16% | 0.94% | - | -99.00% | - |
EPS (Basic) | 9.35 | 6.88 | 2.28 | 0.78 | -0.01 |
EPS (Diluted) | 9.35 | 6.88 | 2.28 | 0.78 | -0.01 |
EPS Growth | 35.90% | 201.75% | 192.52% | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -154.59 | -30.88 | 0.72 | 6.76 | - |
Free Cash Flow Per Share | -28.52 | -8.50 | 0.20 | 1.88 | - |
Gross Margin | 27.93% | 33.75% | 42.94% | 42.25% | 40.05% |
Operating Margin | 19.78% | 21.91% | 21.40% | 14.60% | -32.61% |
Profit Margin | 15.08% | 15.63% | 16.21% | 9.35% | -65.65% |
Free Cash Flow Margin | -45.99% | -19.30% | 1.42% | 22.51% | - |
EBITDA | 69.08 | 37.28 | 13.46 | 7.5 | -0.17 |
EBITDA Margin | 20.55% | 23.29% | 26.56% | 24.97% | -2.97% |
D&A For EBITDA | 2.6 | 2.21 | 2.62 | 3.11 | 1.73 |
EBIT | 66.48 | 35.06 | 10.85 | 4.39 | -1.91 |
EBIT Margin | 19.78% | 21.91% | 21.40% | 14.60% | -32.61% |
Effective Tax Rate | 18.40% | 20.69% | 10.14% | 2.37% | - |
Revenue as Reported | 337.16 | 160.08 | 51.97 | 30.71 | 5.89 |
Advertising Expenses | 0.11 | - | - | - | - |